Previous Close | 2.4900 |
Open | 2.5000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 2.4900 - 2.5600 |
52 Week Range | 1.9780 - 3.0900 |
Volume | |
Avg. Volume | 68,170 |
Market Cap | 116.014M |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2500 |
Earnings Date | Nov 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.60 |
MAHWAH, N.J., October 23, 2024--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2024 financial results on Wednesday, November 13, 2024. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss th
KORU Medical Systems Inc (KRMD) reports a 22% revenue increase and raises 2024 guidance amid global market advancements and operational efficiencies.